Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- ChecktodayChange DetectedRevision updated to v3.5.0 with v3.4.3 removed.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2. This change does not affect study data or page content.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page layout has been updated with minor text changes; core study details such as eligibility criteria, interventions, and outcomes remain unchanged.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe updates appear to be cosmetic UI refinements to the study record page, with core sections such as Eligibility Criteria, Primary/Secondary Outcomes, and Enrollment unchanged. Overall study details remain the same, and no new or removed information is visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision: v3.4.2 appears on the page, replacing the prior v3.4.1 operational funding notice as part of routine site maintenance. This is a routine site maintenance update and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedA government funding notice about site status was added and the revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.